These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 31931806)

  • 1. Associations of Perfluoroalkyl substances with blood lipids and Apolipoproteins in lipoprotein subspecies: the POUNDS-lost study.
    Liu G; Zhang B; Hu Y; Rood J; Liang L; Qi L; Bray GA; DeJonge L; Coull B; Grandjean P; Furtado JD; Sun Q
    Environ Health; 2020 Jan; 19(1):5. PubMed ID: 31931806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of perfluoroalkyl substances (PFAS) with lipid and lipoprotein profiles.
    Haug M; Dunder L; Lind PM; Lind L; Salihovic S
    J Expo Sci Environ Epidemiol; 2023 Sep; 33(5):757-765. PubMed ID: 37019983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perfluoroalkyl substances and lipid concentrations in plasma during pregnancy among women in the Norwegian Mother and Child Cohort Study.
    Starling AP; Engel SM; Whitworth KW; Richardson DB; Stuebe AM; Daniels JL; Haug LS; Eggesbø M; Becher G; Sabaredzovic A; Thomsen C; Wilson RE; Travlos GS; Hoppin JA; Baird DD; Longnecker MP
    Environ Int; 2014 Jan; 62():104-12. PubMed ID: 24189199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations between lipid/lipoprotein levels and perfluoroalkyl substances among US children aged 6-11 years.
    Jain RB; Ducatman A
    Environ Pollut; 2018 Dec; 243(Pt A):1-8. PubMed ID: 30170203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Association Between Perfluoroalkyl Substances and Lipids in Cord Blood.
    Spratlen MJ; Perera FP; Lederman SA; Robinson M; Kannan K; Herbstman J; Trasande L
    J Clin Endocrinol Metab; 2020 Jan; 105(1):43-54. PubMed ID: 31536623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perfluoroalkyl substances and changes in body weight and resting metabolic rate in response to weight-loss diets: A prospective study.
    Liu G; Dhana K; Furtado JD; Rood J; Zong G; Liang L; Qi L; Bray GA; DeJonge L; Coull B; Grandjean P; Sun Q
    PLoS Med; 2018 Feb; 15(2):e1002502. PubMed ID: 29438414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between perfluoroalkyl substances and serum lipids in a Swedish adult population with contaminated drinking water.
    Li Y; Barregard L; Xu Y; Scott K; Pineda D; Lindh CH; Jakobsson K; Fletcher T
    Environ Health; 2020 Mar; 19(1):33. PubMed ID: 32169067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of gender and obesity in defining correlations between perfluoroalkyl substances and lipid/lipoproteins.
    Jain RB; Ducatman A
    Sci Total Environ; 2019 Feb; 653():74-81. PubMed ID: 30408670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perfluoroalkyl substances and lipid concentrations in the blood: A systematic review of epidemiological studies.
    Ho SH; Soh SXH; Wang MX; Ong J; Seah A; Wong Y; Fang Z; Sim S; Lim JT
    Sci Total Environ; 2022 Dec; 850():158036. PubMed ID: 35973530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enrichment of Triglyceride-Rich Lipoproteins with Apolipoprotein C-I Is Positively Associated with Their Delayed Plasma Clearance Independently of Other Transferable Apolipoproteins in Postmenopausal Overweight and Obese Women.
    Wassef H; Bissonnette S; Dufour R; Davignon J; Faraj M
    J Nutr; 2017 May; 147(5):754-762. PubMed ID: 28356429
    [No Abstract]   [Full Text] [Related]  

  • 11. Prenatal exposure to perfluoroalkyl substances and associations with symptoms of attention-deficit/hyperactivity disorder and cognitive functions in preschool children.
    Skogheim TS; Villanger GD; Weyde KVF; Engel SM; Surén P; Øie MG; Skogan AH; Biele G; Zeiner P; Øvergaard KR; Haug LS; Sabaredzovic A; Aase H
    Int J Hyg Environ Health; 2020 Jan; 223(1):80-92. PubMed ID: 31653559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do perfluoroalkyl substances affect metabolic function and plasma lipids?--Analysis of the 2007-2009, Canadian Health Measures Survey (CHMS) Cycle 1.
    Fisher M; Arbuckle TE; Wade M; Haines DA
    Environ Res; 2013 Feb; 121():95-103. PubMed ID: 23266098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between perfluoroalkyl substances and lipid profile in exposed pregnant women in the Veneto region, Italy.
    Dalla Zuanna T; Savitz DA; Barbieri G; Pitter G; Zare Jeddi M; Daprà F; Fabricio ASC; Russo F; Fletcher T; Canova C
    Ecotoxicol Environ Saf; 2021 Feb; 209():111805. PubMed ID: 33360787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Per- and Polyfluoroalkyl Substances (PFAS) and Lipid Trajectories in Women 45-56 Years of Age: The Study of Women's Health Across the Nation.
    Kang H; Ding N; Karvonen-Gutierrez CA; Mukherjee B; Calafat AM; Park SK
    Environ Health Perspect; 2023 Aug; 131(8):87004. PubMed ID: 37552133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early life exposure to per- and polyfluoroalkyl substances and mid-childhood lipid and alanine aminotransferase levels.
    Mora AM; Fleisch AF; Rifas-Shiman SL; Woo Baidal JA; Pardo L; Webster TF; Calafat AM; Ye X; Oken E; Sagiv SK
    Environ Int; 2018 Feb; 111():1-13. PubMed ID: 29156323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma Concentrations of Perfluoroalkyl Substances and Risk of Type 2 Diabetes: A Prospective Investigation among U.S. Women.
    Sun Q; Zong G; Valvi D; Nielsen F; Coull B; Grandjean P
    Environ Health Perspect; 2018 Mar; 126(3):037001. PubMed ID: 29498927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein C-III and its defined lipoprotein subspecies in relation to incident diabetes: the Multi-Ethnic Study of Atherosclerosis.
    Aroner SA; Furtado JD; Sacks FM; Tsai MY; Mukamal KJ; McClelland RL; Jensen MK
    Diabetologia; 2019 Jun; 62(6):981-992. PubMed ID: 30949716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal lipid and apolipoprotein composition of major lipoprotein density classes in patients with chronic renal failure.
    Attman PO; Alaupovic P; Tavella M; Knight-Gibson C
    Nephrol Dial Transplant; 1996 Jan; 11(1):63-9. PubMed ID: 8649654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal Exposure to Perfluoroalkyl Substances and Cardiometabolic Risk in Children from the Spanish INMA Birth Cohort Study.
    Manzano-Salgado CB; Casas M; Lopez-Espinosa MJ; Ballester F; Iñiguez C; Martinez D; Romaguera D; Fernández-Barrés S; Santa-Marina L; Basterretxea M; Schettgen T; Valvi D; Vioque J; Sunyer J; Vrijheid M
    Environ Health Perspect; 2017 Sep; 125(9):097018. PubMed ID: 28934720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PFAS Concentrations and Cardiometabolic Traits in Highly Exposed Children and Adolescents.
    Canova C; Di Nisio A; Barbieri G; Russo F; Fletcher T; Batzella E; Dalla Zuanna T; Pitter G
    Int J Environ Res Public Health; 2021 Dec; 18(24):. PubMed ID: 34948492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.